Amelioration of hypercholesterolemia by an EGFR tyrosine kinase inhibitor in mice with liver-specific knockout of Mig-6. - Wikidata - awgldk - TriplyDB

Amelioration of hypercholesterolemia by an EGFR tyrosine kinase inhibitor in mice with liver-specific knockout of Mig-6.

Amelioration of hypercholesterolemia by an EGFR tyrosine kinase inhibitor in mice with liver-specific knockout of Mig-6.

http://www.wikidata.org/entity/Q34655000

about

Fatty Liver and Insulin Resistance in the Liver-Specific Knockout Mice of Mitogen Inducible Gene-6.Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.

P2860

Q37521565-F46BFE66-276C-43E6-A985-54775E8060E5 Q38287552-65BACE6D-2351-47E2-88EA-F77915F5699A

P2860

Amelioration of hypercholesterolemia by an EGFR tyrosine kinase inhibitor in mice with liver-specific knockout of Mig-6.

http://www.wikidata.org/entity/Q34655000

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@ast

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@en

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@nl

type

label

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@ast

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@en

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@nl

prefLabel

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@ast

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@en

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@nl

P1433

Q34655000-E359FDF9-CBAB-46E0-A54A-080DEA3C2948

P1476

Q34655000-0877757C-6E31-4B73-84A5-DDDB0D5C782B

P2093

Q34655000-12CFE89B-9460-48FD-9559-D1088428036A

Q34655000-24B17813-D853-462A-90A4-05032C29B398

Q34655000-2B2D179B-EDBF-40A5-B167-67AF55244C43

Q34655000-3ED3F684-7752-43AD-BA37-E5CC4C415AC6

Q34655000-9D8ABF6B-80DC-4699-983B-30F062B1F236

Q34655000-B2973873-0717-42E8-9F01-DB9456C95AA6

Q34655000-CF73B3E4-9842-4FDC-8EAC-42725E2E7AF4

Q34655000-D96721EC-790C-45AC-8466-E25C958EDCE8

Q34655000-E8BD553E-12E0-4995-A15F-B449615EC084

Q34655000-EB771E71-A8F5-454C-843A-1F6594220CA7

P2860

Q34655000-11CAAFE4-27E8-4099-8791-53036E5E8FC4

Q34655000-13802E55-4E20-4EBB-A787-7231699313C7

Q34655000-176EDA22-9788-4C58-A08A-B9CA7436699B

Q34655000-1C760D43-6BEE-45D8-AF94-5813CC995526

Q34655000-1FCB1E2F-C868-4C99-9E65-2AB3960A1729

Q34655000-28DF9AB6-8CF7-4D0C-9013-A6A1D44D8F22

Q34655000-29401F1E-C179-4020-AB84-5B9CF39B8AEB

Q34655000-335E0E63-0EC6-494A-A337-923CED7F17ED

Q34655000-3C06D3A6-CD4B-4812-9901-C7DDD4A40A99

Q34655000-3E96AF83-B01A-4C38-8659-F4BECEA57638

P304

Q34655000-22B6A1F9-1962-491B-9948-B212EAED888E

P31

Q34655000-DF11C9EB-34E8-4A2E-BC58-5CD9441E3941

P356

Q34655000-B93A1DD1-3FD9-4AA2-8AFA-5B7C05A75739

P407

Q34655000-95919250-3C17-4BF1-B3B1-E0082B758861

P433

Q34655000-D4DBCADF-3B05-4C55-A6D0-40EE9EE30ADD

P478

Q34655000-12AD4042-C689-4707-864E-01A5F7FE2B50

P50

Q34655000-2B5B2AAD-2D99-4C5C-9E4E-9FBD6A192BB8

P577

Q34655000-73FFA044-EB6A-463F-AD66-8FC7288D92E1

P5875

Q34655000-AEA82002-E63A-4C44-8609-89681A01B3F7

P698

Q34655000-67323F8D-88AC-4176-B24A-CF815D1C8CB3

P921

Q34655000-ECE0CC68-B6AB-4BC6-B96E-76EFAFA5037D

P932

Q34655000-B1541E60-7995-4791-AC42-7442585A10D2

P356

JOURNAL.PONE.0114782

P1433

P1476

Amelioration of hypercholester ...... er-specific knockout of Mig-6.

@en

P2093

Byung Kil Park

http://www.w3.org/2001/XMLSchema#string

Hyun Jin Kim

http://www.w3.org/2001/XMLSchema#string

Jae-Wook Jeong

http://www.w3.org/2001/XMLSchema#string

Ji Min Kim

http://www.w3.org/2001/XMLSchema#string

Ju Hee Lee

http://www.w3.org/2001/XMLSchema#string

Jun Choul Lee

http://www.w3.org/2001/XMLSchema#string

Koon Soon Kim

http://www.w3.org/2001/XMLSchema#string

Kyong Hye Joung

http://www.w3.org/2001/XMLSchema#string

Sang Dal Rhee

http://www.w3.org/2001/XMLSchema#string

Sorim Choung

http://www.w3.org/2001/XMLSchema#string

P2860

Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stre

Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain

Statins and renin-angiotensin system inhibitor combination treatment to prevent cardiovascular disease

Mig-6, signal transduction, stress response and cancer

Identification of a novel mitogen-inducible gene (mig-6): regulation during G1 progression and differentiation

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

Erlotinib in previously treated non-small-cell lung cancer

ERBB receptors and cancer: the complexity of targeted inhibitors

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.

Mig-6 plays a critical role in the regulation of cholesterol homeostasis and bile acid synthesis.

P304

e114782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0114782

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269281846

http://www.w3.org/2001/XMLSchema#string

P698

25486251

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

4259477

http://www.w3.org/2001/XMLSchema#string